Daily Care for December 30, 2020
advertisement
- Type 1 Diabetes Screen Costing $55 Is Launched in US
- Pregnancy and type 1 diabetes: updates on technology and treatment (HTML)
- Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes – significance of pregnancy planning and prepregnancy HbA1c (HTML)
- The psychopathology of recurrent diabetic ketoacidosis: a case-control study (HTML)
- Effects of mobile health interventions on improving glycemic stability and quality of life in patients with type 1 diabetes: A meta-analysis
- Identifying the ‘Achilles Heel’ of type 1 diabetes (HTML)
- Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Results from the German Cohort of a Global Survey of People with Type 1 Diabetes or Insulin-Treated Type 2 Diabetes and Caregivers (HTML)
- Glycemic control and complications of type 1 diabetes among children in Tanzania (HTML)
- Type 1 Diabetes Mellitus in Pediatric Patients and Its Impact on Relationships in the Family Environment (HTML)
- Motivational Interviewing and Self-Care in Type 1 Diabetes: A Randomized Controlled Clinical Trial Study Protocol (HTML)
- Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes (HTML)
- Reliability and validity of the Diabetes Eating Problem Survey in Greek adults with type 1 diabetes mellitus (HTML)
- Internal structure and psychometric properties of Diabetes Distress Scale for Type 1 Diabetes (HTML)
- Effectiveness and equity of continuous subcutaneous insulin infusions in pediatric type 1 diabetes: a systematic review and meta-analysis of the literature
- Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: a new chance to improve the directives? (HTML)
- Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey (HTML)
- The presence of microvascular complications is associated with a poor evolution of metabolic control in patients with type 1 diabetes mellitus
- Variability of Clinical Practice Management of Type 1 and Type 2 Diabetes During Surgery Across Canada (HTML)
- An Analysis of Self-Reported Barriers to Type 1 Diabetes Care in a Pediatric Population in British Columbia, Canada (HTML)
- The Prevalence of Autoimmune Diseases in Longstanding Diabetes: Results from the Canadian Study of Longevity in Adults with Type 1 Diabetes (HTML)
- Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up (HTML) – also available in Spanish
- Separating Insulin-Mediated and Non-Insulin-Mediated Glucose Uptake during Aerobic Exercise in People with Type 1 Diabetes (HTML)
- Perceived Burdens and Benefits Associated with Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan (HTML)
- Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes (HTML)
- Less nocturnal hypoglycemia but equivalent time in range among adults with type 1 diabetes using insulin pumps versus multiple daily injections (HTML)
- Low carbohydrate diets in eating disorders and type 1 diabetes (HTML)
- Early Diagnosis and Management of Bulimia Nervosa in Type 1 Diabetes
